PATENT CLAIM ANALYSIS

Application Number: 15965114
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "262100"]

Abstract:
Disclosed herein are methods for treating a cancer comprising: a. administering a Btk inhibitor to a subject sufficient to result in an increase or appearance in the blood of a subpopulation of lymphocytes defined by immunophenotyping; b. determining the expression profile of one or more biomarkers from one or more subpopulation of lymphocytes; and c. administering a second agent based on the determined expression profile.

Claim (Index 158):
The method of  claim 155 , wherein the human subject is an adult suffering from a hematological malignancy selected from the group consisting of mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, and ABC-diffuse large B-cell lymphoma and the therapeutically effective amount is 560 mg administered in four of said capsules.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.4375
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15066600', '15659803', '15054952', '15066491', '14091196']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.846587605535417
- 35 USC 102 Novelty (BERT): 0.6159876142697865
- Combined Prediction Score: 0.8235276064088539
- Mean Citation Score: 743.8886219999997
- Max Citation Score: 755.1629
- Similarity Product: 533.1289610813975

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test